Mr. Harvey: To ask the Secretary of State for Health what recent assessment he has made of the cost of pharmaceuticals in the United Kingdom, the United States of America and other European Union countries; and if he will make a statement. 
27 Feb 2001 : Column: 618W
Ms Stuart: Regular comparisons are made between the prices of medicines in these countries and the results published in "The Pharmaceutical Price Regulation Scheme: Report to Parliament". The most recent edition of this (the fourth report) was published in December 2000. Copies are in the Library and the text is also on the Department of Health website at www.doh.gov.uk/pprs/ pprs-reports.htm.
The medicines compared (which are those with the highest sales to the National Health Service) are branded rather than generic, because in many countries unbranded generic medicines are not available.
Dr. Naysmith: To ask the Secretary of State for Health (1) if he will estimate the additional cost to the NHS of treating all adults with haemophilia in England who are receiving plasma treatment products with recombinant genetically engineered products; 
27 Feb 2001 : Column: 619W
Mr. Denham: Based on figures provided by the United Kingdom Haemophilia Centre Doctors Organisation, we estimate that approximately 13 per cent. of adult haemophilia A patients and 4 per cent. of haemophilia B patients in England are currently receiving recombinant clotting factors. We estimate the additional cost of providing all adult haemophilia patients with recombinant clotting factors at around £50 million per annum.
Dr. Naysmith: To ask the Secretary of State for Health what differences there are between the provision of recombinant genetically engineered haemophilia treatment products for (a) adults and (b) children in (i) England, (ii) Scotland, (iii) Wales and (iv) Northern Ireland. 
Mr. Denham: In England, all new haemophilia patients and children under 16 are treated with recombinant clotting factors. Scotland, Wales and Northern Ireland provide, or are in the process of providing, recombinant clotting factors for all haemophilia patients.
27 Feb 2001 : Column: 620W
Dr. Naysmith: To ask the Secretary of State for Health what counselling and advice his Department has made available to haemophilia patients who have received treatment products which are traced to a blood donor who has died of vCJD. 
Mr. Denham: The United Kingdom Haemophilia Centre Doctors Organisation, in consultation with the Department, has agreed a policy of giving all haemophilia patients information about such incidents and offering them a choice to know if they or their children received implicated clotting factors. Counselling and advice to patients will be provided by haemophilia centres.
Mr. Field: To ask the Secretary of State for Health if he will list the IT projects currently undertaken in his Department; and if he will state the (a) expected completion date and (b) cost of each project. 
27 Feb 2001 : Column: 619W
|Expected Completion Date
|Estimated Cost (£000)
|Children In Need 3
|Children Looked After 4
|DH Communications Unit Resource Management System
|Care and Health Information Portfolio 4
|Computer Aided Facilities Management System
|Computerisation of Medical Benefits System
|Food Standards Agency (IT Infrastructure set-up & Relocation)
|Financial Infromation Management System (Phase 1)
|Interim NHS Benchmarking System
|Internet Data Collection for Local Authorities
|NHS Estates Knowledge Database
|NHS Estates Business Systems
|Research and Development Programme Management System
|Management of Electronic Documents Strategy
|Regional Office Historic Data Project
|Remote Working Improvements Project
|National Care Standards Commission IS Infrastructure
|National Care Standards Commission Registration and Inspection Package
|National Care Standards Commission Finance Package
|National Care Standards Commission Pay and Personnel System
|Medical Devices Agency Integrated System for Information Sharing
|NHS Pension Agency E-Pensions Zone
|Public Health Laboratory Service CoSurv/lablink
27 Feb 2001 : Column: 619W
Mr. Field: To ask the Secretary of State for Health if he will list the IT projects his Department plans to undertake in the next year; and if he will state in each case the (a) expected date of commencement and completion and (b) cost. 
27 Feb 2001 : Column: 620W
reporting to the police cases where, in the course of their duty, a nurse strongly suspects a child of being a victim of sexual abuse. 
Mr. Hutton: Nurses are well placed to identify when a child may be suffering, or be at risk of significant harm. Like any other professional, a nurse must take appropriate action in accordance with locally agreed procedures, if he or she believes that a child is at such risk. This may involve a referral to local child protection services, which may include the police who then inquire as appropriate into the circumstances of the case.
The "Working Together to Safeguard Children" guidance, published by the Government in 1999, and "Child Protection--Guidance for Senior Nurses, Health Visitors and Midwives and their Managers", a report of the Standing Nursing and Midwifery Advisory Committee, published in 1997, together set out in detail the crucial role that nurses play in child protection.
27 Feb 2001 : Column: 621W
Mr. Burstow: To ask the Secretary of State for Health if full multidisciplinary investigations are carried out in accident and emergency departments of all cases where babies have been shaken. 
Mr. Hutton: If a member of staff working in a hospital accident and emergency department believes that a child may be suffering, or may be at risk of suffering, significant harm appropriate action must be taken immediately in accordance with local procedures. This may involve a referral to local child protection services, which may include the police who then inquire as appropriate into the circumstances of the case.
The "Working Together to Safeguard Children" guidance, published by the Government in 1999, sets out how all agencies with child protection responsibilities should work together to safeguard children and promote their welfare. We are currently developing supplementary guidance to "Working Together" which will focus on the role of all health professionals in child protection.
Mr. Burstow: To ask the Secretary of State for Health what information on specific treatment services provided to children at risk of abusing other children within the Quality Protects Programme is available. 
Mr. Hutton: The Department does not seek from local authorities specific information on what services are made available under the Quality Protects Programme to children at risk of abusing other children.
However, children at risk of abusing other children are likely to have considerable, and often complex, needs. Local authorities are expected to work closely with their partner agencies to ensure that such children receive support and treatment based on their assessed needs.
Mr. Hutton: We are committed to researching into the nature and extent of child abuse and its causes. Development of policy aimed at tackling child maltreatment is informed and influenced by published research in this complex field such as that carried out by the National Society for the Prevention of Cruelty to Children. The revised "Working Together to Safeguard Children" (1999) guidance on child protection reflects the key messages from a programme of research studies into child protection issues commissioned by the Department of Health, "Child Protection: messages from research" (1995).
We regularly commission research into the needs of children and the impact of services which aim to promote and safeguard the welfare of children. The total cost of this programme for the current financial year is approximately £2.5 million. Projects considering the causes, directly or in part, of child abuse include: a study of the onset of sexually abusive behaviour in boys who were sexually abused in early childhood; a study aimed at advancing knowledge about the psychological maltreatment of a specific group of children: those singled
27 Feb 2001 : Column: 622W
out from their siblings and rejected by their birth parents and the comparative costs and outcomes of different interventions for sexually abused children.